Compounds > taprostene

taprostene and Vascular-Diseases

taprostene has been researched along with Vascular-Diseases* in 2 studies

Reviews

1 review(s) available for taprostene and Vascular-Diseases

Article	Year
Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease. Progress in clinical and biological research, 1989, Volume: 301 Topics: Alprostadil; Clinical Trials as Topic; Epoprostenol; Humans; Iloprost; Prostaglandins; Prostaglandins, Synthetic; Vascular Diseases	1989

Trials

2 trial(s) available for taprostene and Vascular-Diseases

Article	Year
Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease. Progress in clinical and biological research, 1989, Volume: 301 Topics: Alprostadil; Clinical Trials as Topic; Epoprostenol; Humans; Iloprost; Prostaglandins; Prostaglandins, Synthetic; Vascular Diseases	1989
Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue. Progress in clinical and biological research, 1987, Volume: 242 Topics: Aged; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Epoprostenol; Half-Life; Humans; Male; Middle Aged; Pain; Prostaglandins, Synthetic; Random Allocation; Vascular Diseases	1987